Top Markets
Coin of the day
Golden Biotechnology Corporation Golden Biotechnology Corporation

Golden Biotechnology Corporation

4132
Rang in aandelen #29679
Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City,... Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City, Taiwan, is engaged in both pharmaceutical drug discovery and the production of health-enhancing dietary supplements. The company operates internationally, serving markets in Taiwan, the United States, Japan, China, Korea, and Singapore. Its varied product line includes several health supplements: Liverty, formulated to support liver function and help alleviate fatigue. Rasle, which serves as an adjunctive therapy for autoimmune conditions. ZSAINO, a nutritional product designed to aid recovery from illness and boost general well-being. UMOOZE, a specialized herbal blend targeting optimal health for men. Furthermore, Golden Biotechnology is developing Antroquinonol, an anticancer molecule. This compound is currently utilized in the treatment of severe conditions such as pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, in addition to addressing hypercholesterolemia and hyperlipidemia.
Aandeelprijs
$0.11034263
Laatst gesynchroniseerd: 2026-04-09
Marktkapitalisatie
$20.11M
Verandering (1 dag)
-31.83%
Verandering (1 jaar)
-73.09%
Land
TW
Handel Golden Biotechnology Corporation (4132)

Categorie

Aandelsplitsingen voor Golden Biotechnology Corporation (4132)
Het aandeel Golden Biotechnology Corporation (symbool: 4132) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 19, 2026.
Eén aandeel 4132 dat vóór Aug 19, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 4132.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten